Latest news with #MorningBrief:MarketSunrise
Yahoo
20 hours ago
- Business
- Yahoo
Astrazeneca, Phillip Morris & D.R. Horton earnings: Trending Tickers
Astrazeneca (AZN) announced plans to invest $50 billion in the US as President Trump threatens the pharmaceutical industry with tariffs. Phillip Morris (PM) revenue fell short of Wall Street estimates, but the company lifted its full-year adjusted earnings outlook. D.R. Horton (DHI) stock popped after posting Q3 results that topped analysts' expectations. To watch more expert insights and analysis on the latest market action, check out more Morning Brief: Market Sunrise here. Well, it's time now for today's Trending Tickers: AstraZeneca, Philip Morris, and DR Horton. First up, AstraZeneca. Well, it plans to invest $50 billion by 2030 in the U.S., becoming the latest pharmaceutical giant to ramp up investment in the wake of President Trump's tariff threats to the industry. The investment includes building new drug factories and expanding research and development centers. The cornerstone of the investment is a multi-billion dollar drug substance manufacturing center focused on chronic diseases in Virginia. This is the company's largest single investment in a facility to date. The announcement follows similar moves by Eli Lilly, Johnson & Johnson, and Novartis, among others. Now, President Trump has demanded more reshoring of domestic manufacturing and recently threatened tariffs within the industry of up to 200%. Okay, next up, a couple of earnings movers, starting with Philip Morris. Now, reporting second-quarter revenue of $10.14 billion versus $10.3 billion that was expected. So, a miss there. And adjusted earnings per share of $1.91 versus $1.86 estimated. Shares in pre-market down there. Now, over 3%, actually. Now, the company boosting its full-year adjusted EPS forecast, seeing $7.43 to $7.56. It previously saw $7.36 to $7.49. Now, in the third quarter, the company expects total product volume to grow about 1% for the year. Going into the report, analysts touted the company's growth of smoke-free products, including Zen, a product of, a brand of tobacco-free nicotine. And finally, DR Horton is also out with mixed quarterly results, reporting third-quarter revenue of $9.23 billion versus $8.76 billion estimated, and diluted earnings per share of $3.36 versus $2.90 estimated. The company narrowing its revenue forecast for the full year, seeing revenue of $33.7 billion to $34.2 billion versus a previously seen range of $33.3 billion to $34.8 billion. Outlook also sees 85, roughly 85,000 homes closed in the year. The firm's executive chairman saying new home demand continues to be impacted by ongoing affordability constraints and cautious consumer sentiment. They expect sales incentives to remain elevated and increase further during the fourth quarter. Related Videos Lockheed Martin, AstraZeneca, DR Horton: Trending Tickers Fresh record highs, GM & Coca-Cola earnings, Powell: 3 Things Credit Market Resilient Amid Pockets of Stress: BlackRock's Lynam Coca-Cola & defense earnings, Powell remarks: What to Watch Sign in to access your portfolio
Yahoo
2 days ago
- Automotive
- Yahoo
Stellantis expects $2.7B loss partly from tariffs: What to know
Stellantis (STLA) expects a net loss of $2.7 billion for the first half of 2025, due partially to the effects of tariffs. Yahoo Finance's Ramzan Karmali, who hosts Morning Brief: Market Sunrise, joins Market Catalysts with Julie Hyman to discuss the details. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts here. Stellantis expects to swing to a net loss of $2.7 billion for the first half of the year due to pre-tax net charges and the effects of tariffs. Here with more context is the host of Market Sunrise, Ramzan Kamal. Ramzan, what's going on here? I mean, we've heard from the various European automakers and they're a little bit all over the map with the sort of reaction to tariffs and how they're handling all of it. Yes, so it's interesting, you know, don't forget Stellantis is the fourth largest car maker in the whole world. It's responsible for 14 brands. You know, probably know them for Chrysler and Dodge and Ram. And this loss of $2.7 billion, on the face of it, looks pretty bad, but it looks even worse if you compare it to the same period last year. Last year, it was actually making, for the same period, a profit of $6.5 billion roughly. So this number is pretty dramatic. They say that about $350 million is down to the tariffs, but it's also facing some huge charges. For instance, it's decided to pull out of making hydrogen cars and that's cost it money. But also it's facing charges of around, in total, around $3.85 billion, and that's also to do with new EU regulations on carbon emissions as well. Its light vehicles, commercial light vehicles have been pretty slow at changing over to being battery-only, battery-only engines. So that's really hurt it as well. So the business itself is also going through a bit of an upheaval as well, it's fair to say. You might remember Carlos Tavares who was the CEO for four years roughly. He quit suddenly in December. For four months, they didn't have a permanent CEO. It was an interim CEO and the actual current CEO only started in April. He was the boss of the North America division, Antonio Filosi, and he is being charged basically with turning the business around and resetting the on switch for Stellantis. Ramzan, all of that sounds like an uphill battle. Um and yet the shares are higher at the moment. What's going on there? So the shares in, so, well, for instance, Stellantis has shares listed not just in New York, but also in Milan and Paris as well. In Milan, in early trade, they were down over 4% at one point. They've recovered there. In the US, you can see they're up now around over 2%, but they were down in pre-market quite heavily as well. What's going on here is I think that maybe there might have been an overreaction perhaps at the start when they saw this big loss, but analysts also point out that actually Stellantis, compared to its rivals, is quite well positioned in North America. And North America is clearly the problem area for a lot of these European car makers, but Stellantis is quite well positioned because it has a lot of production in the US and it's pretty compliant in terms of tariffs with Mexico and Canada as well. And so I think that probably may be outweighing some of the doom and gloom that we may have heard earlier. Right. And also, context here, the shares are down 28% this year, at least the US shares, even with the little bit of a bump today. Ramzan, thank you so much, appreciate it. Exactly. Related Videos Why so many companies are trying to become banks Trump's tariffs: Lutnick reaffirms Aug 1 'hard deadline' Trump's 'hard deadline,' the case for Powell, Stellantis: 3 Things IPO outlook: Why you can expect 'more activity' this fall Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 days ago
- Business
- Yahoo
Johnson & Johnson outlook, MP Materials surges: Trending Tickers
Johnson & Johnson (JNJ) shares tick higher in pre-market trading after the company raised its full-year earnings and sales guidance, though looming pharmaceutical tariffs from President Trump remain a key risk for the sector. MP Materials (MP) stock jumped after Apple (AAPL) announced a $500 million deal to buy rare earth magnets and build a rare earth recycling facility in California. To watch more expert insights and analysis on the latest market action, check out more Morning Brief: Market Sunrise here. Now some more breaking news on the earnings front, as the pharma sector braces for more clarity on tariffs. Johnson & Johnson reporting earnings this morning, kicking off earnings for the healthcare sector. The company reporting second quarter adjusted EPS of $2.77, but keep, keep part of this release really is the company boosting its full-year sales outlook and boosting its full-year earnings outlook, its profit outlook. So Johnson & Johnson now seeing full year adjusted earnings per share in a range of $10.80 to $10.90, previously it had guided for a range of $10.50 to $10.70. On full-year sales, the company now sees a range of $93 or sorry, $93.2 billion to $93.6 billion, previously it had seen a range of 91 to 91.8. So you're seeing stock slightly higher here up a little bit over 1% on this boosted forecast. But key though for the sector, as we had talked about earlier this morning for Johnson & Johnson, is the fact that pretty soon President Trump has warned that there will be tariffs coming on the pharma sector. So it will be interesting to see of course how those could impact this company, what management says on the call about this about those tariffs and looming risks when it comes to that. Now you might have also heard about MP Materials in recent days. That stock closed 20% higher on Tuesday, and this is another trending ticker that I want to highlight for us. That stock is up about 4.5% in pre-market up almost 4% now. The fresh surge in MP, that's the ticker, comes after Apple announced that it would buy rare earth magnets from the company in a $500 million deal. The deal will sell, we'll see Apple and MP materials launch a recycling facility in California for processing and we'll be keeping a close eye on MP materials over the next several sessions.
Yahoo
15-07-2025
- Business
- Yahoo
S&P 500 targets raised amid market rally: Call of the Day
Wall Street is raising its S&P 500 (^GSPC) targets after a sharp two-month rally, with RBC Capital Markets now calling for 6,250 by year-end. Yahoo Finance Reporter Josh Schafer explains why some strategists still expect volatility ahead amid ongoing tariff uncertainty. To watch more expert insights and analysis on the latest market action, check out more Morning Brief: Market Sunrise here. It's time now for our call of the day. Wall Street growing increasingly bullish on its full-year outlook for the S&P 500 amid a massive rally for the benchmark index over the past two months. RBC capital markets, the latest firm to boost their S&P 500 target, RBC's head of US equity strategy, Lori Calvasina, writing in a note to clients on Sunday, they've raised their year-end target to 6,250 from a prior target of 5,730 with a target reflecting a roughly flat return for the rest of the year. Calvasina writes she feels neutral on equities. Now you can see on your screen here, RBC is one of nine firms now that have raised their S&P 500 target over the last several months amid this massive rally that we've seen in the market, but really what Calvasina is sort of expressing here, they think that the rally might be perhaps overextended at this point or at least see a little bit of chop. Ed Yardney of Yardney Research, who's also on our chart there at 6,500, pointed out that it's been a V-shaped recovery for stocks since April, but he wrote in a note to clients on Sunday, even his path to 6,500 doesn't look very linear right now. Yardney noted that instead of a V-shape, we might start turning into a little bit of a square root shape here where stocks have come all the way back up and maybe we go flat for a little bit. Key right now of what strategists are watching is essentially the tariff back and forth. Someone like Yardney had expected the tariff back and forth or the quote Trump tariff turmoil, as he calls it, to be over by now. But we're in the middle of July, we now have an August 1st deadline coming, and it remains unclear exactly when this is going to be solved. So for now, perhaps maybe wait and see and a little bit of chop with the market near record highs. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11-07-2025
- Business
- Yahoo
Nvida hits $4T market cap, who is next?
Nvidia (NVDA) became the first publicly traded company with a market capitalization of over $4 trillion. Ramzan Karmali examines who could follow in the AI chipmaker's historic footsteps. To watch more expert insights and analysis on the latest market action, check out more Morning Brief: Market Sunrise here. So, let's take a look at what's moving markets. Well, on Wednesday, Nvidia led a tech fueled rally that saw the AI company leap to become the world's first $4 trillion public company. The chipmaker has already surpassed Apple's $3.92 trillion valuation it reached last December. And Nvidia's rise to a $4 trillion company has had implications in the markets in Asia today. Tech stocks there also rose sharply. In fact, since early May, Nvidia's share price is up more than 40%. That coincides with when President Trump first signaled a thaw in his trade war with China and Nvidia struck a series of multi-billion dollar deals in the Middle East. The stock's recent rally follows a sluggish start to the year when the emergence of Chinese discount AI model developed by Deepseek shook confidence linked to the sector. Nvidia's soaring market value underscores Wall Street's confidence in the rapid growth of AI, with the company's high-performance chips forming the backbone of this technological advance. Optimism around trade partners reaching deals with the US has recently lifted stocks with the S&P 500 hitting an all-time high. Nvidia accounts for 7.3% of the index, with Apple at 7% and Microsoft at 6%. Microsoft is actually the second most valuable US company worth $3.74 trillion. In fact, Nvidia is now worth more than the combined value of the Canadian and Mexican stock markets. But one note of caution, perhaps, while Nvidia's chips dominate the AI industry, the likes of Amazon, Microsoft and Alphabet have faced pressure from investors to rein in heavy AI spending. And while Microsoft keeps inching closer to that coveted $4 trillion mark, other behemoths in the MAG 7 like Tesla and Apple have actually been trending down lately. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
